Drawing for ADDISON CARE

USPTO serial 88587191

ADDISON CARE

Reviewed by CopyMark Law Group

Reg. 7189900Status 700Registered
Filing date
Status date
Registration date
Oct 10, 2023
Examiner
WRIGHT, MARCO JABBAR
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ADDISON CARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jefferson F. Scher

Jefferson F. Scher CARR & FERRELL LLP120 CONSTITUTION DRIVEMENLO PARK, CA 94025UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Software as a service (SAAS) services featuring software for motion assessment of daily activity; software as a service (SAAS) services featuring software for tracking, analyzing and assessing daily activity; software as a service (SAAS) services featuring software for tracking medication compliance; software as a service (SAAS) services featuring software for use in notifying users based on performance; software as a service (SAAS) services featuring software for monitoring, collecting and assessing vitals; software as a service (SAAS) services featuring software to process and analyze biological and physiological signals for indication of user condition, functional capacity, including changes in such parameters of health stability, improvement, or decline; software as a service (SAAS) services featuring software for identification of and intervention with at-risk individuals in the field of health and wellness; software as a service (SAAS) services featuring software for use in identifying health stability, improvement or decline; software as a service (SAAS) services featuring software for the administration of disease specific plans of care; software as a service (SAAS) services featuring software for setting and monitoring progress toward meeting individual goals in the management of physical function maintenance; software as a service (SAAS) services featuring software for use in setting, tracking, and monitoring treatment plans and individual goals to manage and improve personal health and disease status; software as a service (SAAS) services featuring software for creating and sharing personalized plans of care based on users disease profile; software as a service (SAAS) services featuring software for collection, analysis and reporting of personal health and wellness data; Software as a service (SAAS) services featuring an interactive conversational software that enables users to access, enter, track, monitor and generate health and medical information and reports; software as a service (SAAS) services featuring software for emergency monitoring; software as a service (SAAS) services featuring software for electronic storage of medical and person contact information for use in the event of a medical emergency; software as a service (SAAS) services featuring interactive software for assistance in the field of health care and disease prevention; software as a service (SAAS) services featuring software for accessing physicians, medical specialists, nurses, healthcare professionals and healthcare service providers for the purposes of obtaining medical and healthcare services, counseling, advice and pharmaceutical prescriptions; software as a service (SAAS) services featuring software for remote patient monitoring; software as a service (SAAS) services featuring software for remote patient monitoring for collecting and transmitting patient information in the field of health care and disease prevention; Software as a service (SAAS) services featuring software for managing and tracking nutritional plans; software as a service (SAAS) services featuring software for disease profiling, managing and monitoring individual health status; software as a service (SAAS) services featuring predictive analytical software with the capacity to identify disease progression; software as a service (SAAS) services featuring predictive analytical software to notify users of impeding adverse events; software as a service (SAAS) services featuring voice recognition software; software as a service (SAAS) services featuring speech processing softwareACTIVEJan 7, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 10, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 10, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 6, 2023SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 5, 2023CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 14, 2023DOCKASSIGNED TO EXAMINER—
Aug 1, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 27, 2023IUAFUSE AMENDMENT FILED—
Jul 27, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 1, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 1, 2023NOACCORRECTED NOA E-MAILED—
Feb 28, 2023EX5GSOU EXTENSION 5 GRANTED—
Feb 28, 2023DPCCDIVISIONAL PROCESSING COMPLETE—
Feb 28, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 28, 2023EXT5SOU EXTENSION 5 FILED—
Jan 28, 2023DRRRDIVISIONAL REQUEST RECEIVED—
Jan 28, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 28, 2023ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Jul 30, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 28, 2022EX4GSOU EXTENSION 4 GRANTED—
Jul 28, 2022EXT4SOU EXTENSION 4 FILED—
Jul 28, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 11, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 11, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Feb 11, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 11, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 29, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 27, 2022EX3GSOU EXTENSION 3 GRANTED—
Jan 27, 2022EXT3SOU EXTENSION 3 FILED—
Jan 27, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 28, 2021EX2GSOU EXTENSION 2 GRANTED—
Jul 28, 2021EXT2SOU EXTENSION 2 FILED—
Jul 28, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 30, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 28, 2021EX1GSOU EXTENSION 1 GRANTED—
Jan 28, 2021EXT1SOU EXTENSION 1 FILED—
Jan 28, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 28, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 2, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 2, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 13, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 23, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 23, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 22, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 22, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 22, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 22, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 22, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 20, 2019DOCKASSIGNED TO EXAMINER—
Nov 8, 2019AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Nov 7, 2019ALIEASSIGNED TO LIE—
Nov 1, 2019PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Sep 5, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 26, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance